X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-01-17 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $17.23 | -9,781 | 194,605 | -5% | -$168,527 | ||||||
2024-01-17 | PLRX | Hull Hans | Chief Business Officer | S - Sale | $17.23 | -9,786 | 216,860 | -4% | -$168,613 | ||||||
2024-01-17 | PLRX | Coulie Bernard | Pres, CEO | S - Sale | $17.23 | -25,721 | 725,699 | -3% | -$443,173 | ||||||
2024-01-17 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $17.23 | -10,295 | 156,920 | -6% | -$177,383 | ||||||
2024-01-17 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $17.23 | -5,197 | 55,246 | -9% | -$89,544 | ||||||
DM | 2023-08-03 | PLRX | Hull Hans | Chief Business Officer | S - Sale+OE | $20.01 | -34,919 | 226,646 | -13% | -$698,581 | |||||
2023-07-20 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $17.55 | -4,755 | 60,443 | -7% | -$83,450 | ||||||
2023-07-17 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $18.01 | -12,778 | 65,198 | -16% | -$230,120 | ||||||
2023-07-17 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $18.01 | -22,321 | 167,215 | -12% | -$401,981 | ||||||
2023-07-17 | PLRX | Hull Hans | Chief Business Officer | S - Sale | $18.01 | -17,937 | 250,974 | -7% | -$323,029 | ||||||
2023-07-17 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $18.01 | -19,771 | 203,999 | -9% | -$356,058 | ||||||
2023-07-17 | PLRX | Coulie Bernard | Pres, CEO | S - Sale | $18.01 | -70,150 | 751,420 | -9% | -$1,263,338 | ||||||
M | 2023-03-30 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $26.62 | -7,751 | 50,789 | -13% | -$206,329 | |||||
2023-03-30 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $26.52 | -11,245 | 145,786 | -7% | -$298,228 | ||||||
2023-03-30 | PLRX | Hull Hans | Chief Business Officer | S - Sale | $26.52 | -9,036 | 233,755 | -4% | -$239,643 | ||||||
2023-03-30 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $26.52 | -9,960 | 148,470 | -6% | -$264,148 | ||||||
2023-03-30 | PLRX | Coulie Bernard | Pres, CEO | S - Sale | $26.52 | -35,339 | 684,070 | -5% | -$937,222 | ||||||
DM | 2023-02-02 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $33.91 | -30,000 | 649,429 | -4% | -$1,017,430 | |||||
DM | 2023-01-30 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $34.48 | -45,000 | 649,429 | -6% | -$1,551,637 | |||||
DM | 2023-01-26 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $35.32 | -55,000 | 649,429 | -8% | -$1,942,336 | |||||
DM | 2023-01-23 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $33.12 | -60,000 | 528,129 | -10% | -$1,987,473 | |||||
D | 2023-01-23 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale+OE | $34.19 | -20,000 | 5,947 | -77% | -$683,878 | |||||
2023-01-23 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $34.48 | -67,500 | 76,926 | -47% | -$2,327,630 | ||||||
D | 2023-01-23 | PLRX | Cummings Keith Lamont | CFO | S - Sale+OE | $35.00 | -30,000 | 84,424 | -26% | -$1,050,000 | |||||
DM | 2023-01-06 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $19.07 | -20,000 | 543,129 | -4% | -$381,413 | |||||
DM | 2023-01-03 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $19.20 | -30,000 | 543,129 | -5% | -$575,892 | |||||
2022-12-22 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $19.38 | -2,928 | 5,947 | -33% | -$56,731 | ||||||
2022-12-20 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $19.10 | -9,643 | 80,424 | -11% | -$184,204 | ||||||
2022-12-20 | PLRX | Coulie Bernard | Pres, CEO | S - Sale | $19.10 | -34,212 | 543,129 | -6% | -$653,531 | ||||||
2022-12-20 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $19.10 | -10,887 | 144,426 | -7% | -$207,968 | ||||||
2022-12-20 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $19.10 | -4,719 | 8,875 | -35% | -$90,144 | ||||||
2022-12-20 | PLRX | Hull Hans | Chief Business Officer | S - Sale | $19.10 | -8,748 | 169,982 | -5% | -$167,108 | ||||||
2022-10-25 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $25.05 | -5,000 | 133,437 | -4% | -$125,241 | ||||||
D | 2022-09-12 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $22.54 | -12,502 | 508,590 | -2% | -$281,851 | |||||
2022-07-11 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $20.00 | -3,000 | 138,436 | -2% | -$60,000 | ||||||
DM | 2022-07-11 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $22.50 | -27,498 | 508,590 | -5% | -$618,705 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |